Drug Discovery Tutorial: Detection and Reduction of Immunogenicity - Abzena

Drug Discovery Tutorial: Detection and Reduction of Immunogenicity

Abstract

Drug Discovery Tutorial: Detection and Reduction of Immunogenicity
This article discusses how early removal of T-cell epitopes reduces risk of adverse immune responses in patients and how technologies such as Composite Human Antibodies can achieve this. Ji-won Choi. GEN; March 2015.

Interested in our services? Get In Touch